AI assistant
Sending…
TransMedics Group, Inc. — Director's Dealing 2023
Aug 4, 2023
31201_dirs_2023-08-04_773b0fe6-287a-4882-8fb7-662a239257fb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TransMedics Group, Inc. (TMDX)
CIK: 0001756262
Period of Report: 2023-08-01
Reporting Person: Ranganath Anil P. (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-08-01 | Common Stock | A | 9512 | — | Acquired | 9512 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-08-01 | Stock Option (Right to Buy) | $93.88 | A | 14709 | Acquired | 2023-08-01 | Common Stock (14709) | Direct |
Footnotes
F1: Includes 9,512 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2: The Option vests as to 25% on August 1, 2024 and as to the remaining shares in equal monthly installments over three years thereafter, subject to continued service.
More from TransMedics Group, Inc.
Regulatory Filings
2026
May 29
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Annual Report
2026
Apr 10
Proxy Solicitation & Information Statement
2026
Apr 10
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Regulatory Filings
2026
Feb 27
Annual Report
2026
Feb 24
Earnings Release
2026
Feb 24
Director's Dealing
2026
Feb 20